MX21219A - Acido cis-(-)-4[(1(2)h-tetrazol-5-il)metil]-2-piperidin-carboxilico y procedimiento para su preparacion. - Google Patents

Acido cis-(-)-4[(1(2)h-tetrazol-5-il)metil]-2-piperidin-carboxilico y procedimiento para su preparacion.

Info

Publication number
MX21219A
MX21219A MX2121990A MX2121990A MX21219A MX 21219 A MX21219 A MX 21219A MX 2121990 A MX2121990 A MX 2121990A MX 2121990 A MX2121990 A MX 2121990A MX 21219 A MX21219 A MX 21219A
Authority
MX
Mexico
Prior art keywords
carboxilico
tetrazol
piperidin
methyl
procedure
Prior art date
Application number
MX2121990A
Other languages
English (en)
Inventor
Paul Leslie Ornstein
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX21219A publication Critical patent/MX21219A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
MX2121990A 1989-06-26 1990-06-19 Acido cis-(-)-4[(1(2)h-tetrazol-5-il)metil]-2-piperidin-carboxilico y procedimiento para su preparacion. MX21219A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/371,568 US4968678A (en) 1988-02-19 1989-06-26 Tetrazole excitatory amino acid receptor antagonists

Publications (1)

Publication Number Publication Date
MX21219A true MX21219A (es) 1993-11-01

Family

ID=23464503

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2121990A MX21219A (es) 1989-06-26 1990-06-19 Acido cis-(-)-4[(1(2)h-tetrazol-5-il)metil]-2-piperidin-carboxilico y procedimiento para su preparacion.

Country Status (17)

Country Link
US (1) US4968678A (es)
EP (1) EP0405834A3 (es)
JP (1) JPH0348679A (es)
KR (1) KR910000703A (es)
CN (1) CN1028024C (es)
AU (1) AU621498B2 (es)
CA (1) CA2019167A1 (es)
FI (1) FI903183A0 (es)
HU (1) HU206339B (es)
IE (1) IE902288A1 (es)
IL (1) IL94777A (es)
MX (1) MX21219A (es)
NZ (1) NZ234109A (es)
PH (1) PH26905A (es)
PT (1) PT94447B (es)
RU (2) RU1833385C (es)
ZA (1) ZA904717B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA891113B (en) * 1988-02-19 1990-10-31 Lilly Co Eli Tetrazole excitatory amino acid receptor antagonists
US5594007A (en) * 1991-04-18 1997-01-14 Pfizer Inc. Method for treating spinal cord trauma with phenolic 2-piperidino-1-alkanols
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
US5196421A (en) * 1991-06-05 1993-03-23 Eli Lilly And Company Excitatory amino acid receptor antagonists in methods for the use thereof
EP0636130A1 (en) * 1992-04-15 1995-02-01 Merck Sharp & Dohme Ltd. Azacyclic compounds
US5192751A (en) * 1992-07-24 1993-03-09 Eli Lilly And Company Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence
JP3666818B2 (ja) * 1993-03-29 2005-06-29 クイーンズ ユニバーシティ アット キングストン アミロイド症の治療法
US20040208875A1 (en) 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
AU684568B2 (en) * 1994-01-31 1997-12-18 Pfizer Inc. Neuroprotective chroman compounds
NZ284852A (en) * 1994-08-18 1998-06-26 Pfizer 3-(piperidin-1-yl)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidin-1-yl) alkanol derivatives; medicaments; used as a neuroprotective agent
US5880138A (en) * 1996-10-01 1999-03-09 Eli Lilly And Company NMDA receptor selective antagonists
US8043303B2 (en) * 2002-10-04 2011-10-25 Cook Medical Technologies Llc Handle for interchangeable medical device
JP2006501957A (ja) * 2002-10-04 2006-01-19 クック ウロロジカル インコーポレイテッド ワイヤバスケットを備えた硬性摘出器具
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
WO2005084564A1 (en) * 2004-02-27 2005-09-15 Cook Urological Incorporated Self-tensioning handle for endoscopic device
CA2900876A1 (en) 2004-12-22 2006-08-17 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
TW200716088A (en) 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
CA2626867C (en) 2005-11-03 2015-08-11 Vance Products Incorporated, D/B/A Cook Urological Incorporated Articulating basket with simultaneous basket extension or basket retraction
ATE481094T1 (de) 2005-12-22 2010-10-15 Kiacta Sarl Behandlung von diabetischer nephropathie
KR101443573B1 (ko) 2006-10-12 2014-11-03 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536715A (en) * 1967-03-24 1970-10-27 Miles Lab 2-lower alkyl-5-(omega-(4-phenyl-1-piperazinyl) lower alkyl)-2h-tetrazoles
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids
PH23848A (en) * 1985-05-24 1989-11-23 Ciba Geigy Ag Certain phosphonic acids and derivatives
US4746653A (en) * 1986-02-28 1988-05-24 Ciba-Geigy Corporation Certain hetero phosphonic acid derivatives of 2-piperidine or 2-tetrahydropyridinecarboxylates and esters thereof which are useful for the treatment of disorders responsive to blockade of the NMDA receptor in mammals
IL84492A0 (en) * 1986-11-21 1988-04-29 Ciba Geigy Ag Unsaturated phosphonic acids and derivatives
ZA891113B (en) * 1988-02-19 1990-10-31 Lilly Co Eli Tetrazole excitatory amino acid receptor antagonists

Also Published As

Publication number Publication date
EP0405834A3 (en) 1991-12-27
RU1833385C (ru) 1993-08-07
IL94777A (en) 1994-05-30
AU621498B2 (en) 1992-03-12
PT94447A (pt) 1991-02-08
CN1028024C (zh) 1995-03-29
HUT54364A (en) 1991-02-28
HU903976D0 (en) 1990-11-28
PH26905A (en) 1992-12-03
RU2089546C1 (ru) 1997-09-10
IL94777A0 (en) 1991-04-15
AU5780890A (en) 1991-01-03
HU206339B (en) 1992-10-28
IE902288A1 (en) 1991-01-16
ZA904717B (en) 1992-02-26
US4968678A (en) 1990-11-06
CN1048385A (zh) 1991-01-09
EP0405834A2 (en) 1991-01-02
PT94447B (pt) 1997-02-28
IE902288L (en) 1990-12-26
NZ234109A (en) 1992-04-28
JPH0348679A (ja) 1991-03-01
FI903183A0 (fi) 1990-06-25
KR910000703A (ko) 1991-01-30
CA2019167A1 (en) 1990-12-26

Similar Documents

Publication Publication Date Title
MX21219A (es) Acido cis-(-)-4[(1(2)h-tetrazol-5-il)metil]-2-piperidin-carboxilico y procedimiento para su preparacion.
MX24568A (es) 3-arilcarbonil-1h-indoles y procedimiento para su preparacion.
MX7372A (es) Drivados de tetrahidronaftalina e indano y procedimiento para su preparacion.
MX23672A (es) Derivados de glicopeptidos y procedimiento para su preparacion.
MX15701A (es) Composiciones de macrolidas y procedimiento para su preparacion.
MX9205032A (es) 1,2-dihidro-2-oxo-piridinas y procedimiento para su preparacion.
MX9201355A (es) Bis-naftal imidas y metodo para su preparacion.
MX16687A (es) Compuestos de biarilo y procedimiento para su preparacion.
MX26267A (es) Aminobenzodiacepinas y procedimiento para su prepaacion.
MX9201780A (es) Eteres oximicos y procedimiento para su preparacion.
MX22255A (es) Compuestos de piridinil-quinolona y procedimiento para su preparacion.
MX9204940A (es) Compuesto antiparasitario y procedimiento para su preparacion.
MX9100845A (es) Nuevas tienodiazepinas y procedimiento para su preparacion
MX21243A (es) Indenoindoles y procedimiento para su preparacion.
MX9101516A (es) Derivados de 1,2,5,6-tetrahidropiridin 3-cetoxima y-3-aldoxina y procedimiento para su preparacion
MX9102630A (es) Derivados de benzamida y proceso para su preparacion.
MX9205747A (es) Pirazolinas y procedimiento para su preparacion.
MX9100811A (es) Indolonaftiridinas y procedimiento para su preparacion
MX7829A (es) Quinazolindionas y piridopirimindionas y procedimiento para su preparacion
MX9205746A (es) Pirazolinas y procedimiento para su preparacion.
MX9205457A (es) Nuevos compuestos derivados de mupirocina y procedimiento para su preparacion
MX21871A (es) Procedimiento para la preparacion de oxadiazolil fenoxialquilisoxazoles y compuestos resultantes
ES545701A0 (es) Procedimiento para preparar 9-oxo-15 a-hidroxi-16-fenoxi y 16-fenoxi sustituido-17,18,19,20-tetranorprosta-4,5,13 (e)- trienoatos
MX162953B (es) Articulo fotosensible y procedimiento para su preparacion
MX9101794A (es) Compuestos de trifendioxazina y procedimiento para su preparacion